Cheung, Tan To
University of Hong Kong
2 papers on CoChatORCID 0000-0002-2633-5883
Most cited papers
- Verified
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
Wong, J. S. L., Kwok, G. G. W., Tang, V., Li, B. C. W., Leung, R., Chiu, J., Ma, K. W., She, W. H., Tsang, J., Lo, C. M., et al. (2021) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis
Cited by 142
- Verified
Indications of pro-inflammatory cytokines in laparoscopic and open liver resection for early-stage hepatocellular carcinoma
Ng, K. T.-P., Pang, L., Wang, J.-Q., She, W. H., Tsang, S. H.-Y., Lo, C. M., Man, K., & Cheung, T. T. (2024) · Hepatobiliary & Pancreatic Diseases International
Hepatocellular Carcinoma Treatment and PrognosisCancer, Stress, Anesthesia, and Immune Response
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free